Bank of America
VRTX icon

Bank of America’s Vertex Pharmaceuticals VRTX Stock Holding History

Bank of America’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.29B Sell
2,878,183
-58,847
-2% -$27.4M 0.09% 207
2025
Q4 		$1.33B Buy
2,937,030
+96,606
+3% +$41.6M 0.1% 202
2025
Q3 		$1.11B Buy
2,840,424
+32,807
+1% +$13.7M 0.08% 252
2025
Q2 		$1.25B Sell
2,807,617
-57,381
-2% -$26.4M 0.09% 220
2025
Q1 		$1.39B Buy
2,864,998
+445,645
+18% +$208M 0.11% 179
2024
Q4 		$974M Sell
2,419,353
-189,604
-7% -$87.9M 0.08% 238
2024
Q3 		$1.21B Buy
2,608,957
+36,472
+1% +$17.5M 0.1% 206
2024
Q2 		$1.21B Buy
2,572,485
+27,847
+1% +$12.1M 0.11% 198
2024
Q1 		$1.06B Buy
2,544,638
+108,718
+4% +$46M 0.1% 220
2023
Q4 		$991M Buy
2,435,920
+82,919
+4% +$30.6M 0.1% 212
2023
Q3 		$818M Buy
2,353,001
+12,926
+0.6% +$4.52M 0.09% 225
2023
Q2 		$823M Sell
2,340,075
-245,069
-9% -$82.6M 0.09% 232
2023
Q1 		$815M Buy
2,585,144
+88,084
+4% +$26.4M 0.08% 237
2022
Q4 		$721M Sell
2,497,060
-30,395
-1% -$9.26M 0.08% 237
2022
Q3 		$732M Sell
2,527,455
-169,343
-6% -$48.7M 0.09% 230
2022
Q2 		$760M Sell
2,696,798
-421,749
-14% -$113M 0.09% 230
2022
Q1 		$814M Buy
3,118,547
+20,530
+0.7% +$4.87M 0.08% 235
2021
Q4 		$680M Buy
3,098,017
+67,661
+2% +$13.2M 0.07% 288
2021
Q3 		$550M Buy
3,030,356
+1,497,012
+98% +$292M 0.06% 312
2021
Q2 		$309M Buy
1,533,344
+68,083
+5% +$14.2M 0.03% 478
2021
Q1 		$315M Buy
1,465,261
+114,117
+8% +$25.1M 0.04% 434
2020
Q4 		$319M Sell
1,351,144
-121,966
-8% -$28M 0.04% 379
2020
Q3 		$401M Buy
1,473,110
+43,988
+3% +$12.1M 0.05% 305
2020
Q2 		$415M Buy
1,429,122
+76,775
+6% +$20.8M 0.06% 279
2020
Q1 		$322M Buy
1,352,347
+175,087
+15% +$40.2M 0.06% 288
2019
Q4 		$258M Buy
1,177,260
+305,904
+35% +$61.9M 0.04% 415
2019
Q3 		$148M Sell
871,356
-66,061
-7% -$11.7M 0.02% 581
2019
Q2 		$172M Sell
937,417
-144,891
-13% -$25.3M 0.03% 540
2019
Q1 		$199M Sell
1,082,308
-543,826
-33% -$100M 0.03% 478
2018
Q4 		$269M Sell
1,626,134
-206,511
-11% -$35.8M 0.05% 352
2018
Q3 		$353M Buy
1,832,645
+158,283
+9% +$28.2M 0.06% 323
2018
Q2 		$285M Buy
1,674,362
+33,763
+2% +$5.23M 0.05% 356
2018
Q1 		$267M Buy
1,640,599
+237,673
+17% +$38.8M 0.05% 373
2017
Q4 		$210M Sell
1,402,926
-113,254
-7% -$16.8M 0.04% 438
2017
Q3 		$231M Buy
1,516,180
+341,583
+29% +$51.4M 0.04% 424
2017
Q2 		$151M Sell
1,174,597
-140,138
-11% -$16.9M 0.03% 522
2017
Q1 		$144M Sell
1,314,735
-29,507
-2% -$2.6M 0.03% 545
2016
Q4 		$99M Sell
1,344,242
-41,083
-3% -$3.34M 0.02% 673
2016
Q3 		$121M Sell
1,385,325
-106,334
-7% -$10M 0.03% 557
2016
Q2 		$128M Buy
1,491,659
+24,359
+2% +$2.1M 0.03% 527
2016
Q1 		$117M Sell
1,467,300
-319,268
-18% -$28.9M 0.03% 540
2015
Q4 		$225M Sell
1,786,568
-177,562
-9% -$21.4M 0.05% 365
2015
Q3 		$205M Buy
1,964,130
+1,712,699
+681% +$220M 0.05% 379
2015
Q2 		$31M Buy
251,431
+4,467
+2% +$563K 0.01% 1109
2015
Q1 		$29.1M Buy
246,964
+55,036
+29% +$6.59M 0.01% 1115
2014
Q4 		$22.8M Buy
191,928
+31,672
+20% +$3.57M 0.01% 1295
2014
Q3 		$18M Sell
160,256
-129,221
-45% -$12.3M 0.01% 1480
2014
Q2 		$27.4M Sell
289,477
-198,776
-41% -$13.9M 0.01% 1172
2014
Q1 		$34.5M Buy
488,253
+22,902
+5% +$1.81M 0.01% 943
2013
Q4 		$34.6M Buy
465,351
+147,591
+46% +$10.3M 0.01% 955
2013
Q3 		$24.1M Sell
317,760
-85,353
-21% -$6.79M 0.01% 1144
2013
Q2 		$32.3M Buy
+403,113
New +$29.7M 0.01% 910

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America's VRTX Position: Q1 2026 in Review

Bank of America reduced its Vertex Pharmaceuticals (VRTX) stake by 2% in Q1 2026, selling an estimated $27.4M and leaving 2,878,183 shares worth $1.29B. The position accounts for 0.09% of the portfolio, ranked #207.

Bank of America first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.39B in Q1 2025. 1,689 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Bank of America held 2,878,183 shares of Vertex Pharmaceuticals worth $1.29B as of Q1 2026.
  • Bank of America sold 58,847 Vertex Pharmaceuticals shares in Q1 2026, an estimated $27.4M.
  • Vertex Pharmaceuticals made up 0.09% of Bank of America's portfolio in Q1 2026, its #207 holding.
  • Bank of America first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's Vertex Pharmaceuticals position peaked at $1.39B in Q1 2025.
  • 1,689 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.